SEC Form 4 · accession 0001144204-19-011720
INTERCEPT PHARMACEUTICALS, INC. · ICPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christian Weyer
Officer — EVP, Research & Development
Period of report
Feb 27, 2019
Accepted (ET)
Mar 1, 2019 · 7:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001270073
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2019 | F | 364 | $92.76 | D | 19,440 | D | |
| Common Stock | Mar 1, 2019 | S | 333 | $103.16 | D | 19,107 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person.
- F2This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.